118 related articles for article (PubMed ID: 35523947)
1. Correction: Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells.
Chen S; Cheng J; Zhong Y; Liu R; Lu Z; Luo X
Oncogene; 2022 Jun; 41(24):3381. PubMed ID: 35523947
[No Abstract] [Full Text] [Related]
2. Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells.
Chen S; Cheng J; Zhong Y; Liu R; Lu Z; Luo X
Oncogene; 2022 Jun; 41(24):3316-3327. PubMed ID: 35411035
[TBL] [Abstract][Full Text] [Related]
3. Hepatic myeloid-derived suppressor cells in cancer.
Medina-Echeverz J; Eggert T; Han M; Greten TF
Cancer Immunol Immunother; 2015 Aug; 64(8):931-40. PubMed ID: 26133122
[TBL] [Abstract][Full Text] [Related]
4. GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma.
Chen Y; Liu Q; Wu M; Li M; Ding H; Shan X; Liu J; Tao T; Ni R; Chen X
Tumour Biol; 2016 Sep; 37(9):11763-11773. PubMed ID: 27026230
[TBL] [Abstract][Full Text] [Related]
5. Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.
Cheng J; Zhong Y; Chen S; Sun Y; Huang L; Kang Y; Chen B; Chen G; Wang F; Tian Y; Liu W; Feng GS; Lu Z
FASEB J; 2017 Dec; 31(12):5530-5542. PubMed ID: 28842424
[TBL] [Abstract][Full Text] [Related]
6. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
Hu X; He B; Zhou L; Xie H; Zheng S
Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑663b targets GAB2 to restrict cell proliferation and invasion in hepatocellular carcinoma.
Guo L; Li B; Miao M; Yang J; Ji J
Mol Med Rep; 2019 Apr; 19(4):2913-2920. PubMed ID: 30720118
[TBL] [Abstract][Full Text] [Related]
8. Immune Surveillance by Myeloid-Derived Suppressor Cells in Liver Diseases.
Sehgal R; Kaur N; Ramakrishna G; Trehanpati N
Dig Dis; 2022; 40(3):301-312. PubMed ID: 34157708
[TBL] [Abstract][Full Text] [Related]
9. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen-like protein 2 promotes the accumulation of myeloid-derived suppressor cells in the hepatocellular carcinoma tumor microenvironment.
Liu BQ; Bao ZY; Zhu JY; Liu H
Oncol Lett; 2021 Jan; 21(1):47. PubMed ID: 33281958
[TBL] [Abstract][Full Text] [Related]
11. Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives.
Lu LC; Chang CJ; Hsu CH
J Hepatocell Carcinoma; 2019; 6():71-84. PubMed ID: 31123667
[TBL] [Abstract][Full Text] [Related]
12. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia.
Aumann K; Lassmann S; Schöpflin A; May AM; Wöhrle FU; Zeiser R; Waller CF; Hauschke D; Werner M; Brummer T
Hum Pathol; 2011 May; 42(5):719-26. PubMed ID: 21292300
[TBL] [Abstract][Full Text] [Related]
13. The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy.
Wang D; An G; Xie S; Yao Y; Feng G
Tumour Biol; 2016 Aug; 37(8):10427-33. PubMed ID: 26846107
[TBL] [Abstract][Full Text] [Related]
14. Chronic restraint stress promotes hepatocellular carcinoma growth by mobilizing splenic myeloid cells through activating β-adrenergic signaling.
Jiang W; Li Y; Li ZZ; Sun J; Li JW; Wei W; Li L; Zhang C; Huang C; Yang SY; Yang J; Kong GY; Li ZF
Brain Behav Immun; 2019 Aug; 80():825-838. PubMed ID: 31125710
[TBL] [Abstract][Full Text] [Related]
15. Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation.
Tao H; Liu M; Wang Y; Luo S; Xu Y; Ye B; Zheng L; Meng K; Li L
Front Immunol; 2021; 12():609295. PubMed ID: 33717093
[TBL] [Abstract][Full Text] [Related]
16. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.
Xu Y; Zhao W; Xu J; Li J; Hong Z; Yin Z; Wang X
Oncotarget; 2016 Feb; 7(8):8866-78. PubMed ID: 26758420
[TBL] [Abstract][Full Text] [Related]
17. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis.
Wu L; Yan C; Czader M; Foreman O; Blum JS; Kapur R; Du H
Blood; 2012 Jan; 119(1):115-26. PubMed ID: 22053106
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.
Long X; Wang J; Zhao JP; Liang HF; Zhu P; Cheng Q; Chen Q; Wu YH; Zhang ZG; Zhang BX; Chen XP
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):667-676. PubMed ID: 27752888
[TBL] [Abstract][Full Text] [Related]
20. Jianpi Huayu Decoction Attenuates the Immunosuppressive Status of H
Xie Y; Zhang Y; Wei X; Zhou C; Huang Y; Zhu X; Chen Y; Wen H; Huang X; Lin J; Wang Z; Ren Y; Fan B; Deng X; Tan W; Wang C
Front Pharmacol; 2020; 11():16. PubMed ID: 32140106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
